Is a complete KRRO research report available?

No complete published report is available for Korro Bio, Inc. (KRRO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Korro Bio, Inc. (KRRO)

NASDAQ: KRRO · USD

$13.8

+0.52 (+3.9%)· Recorded snapshot

Market cap	203.5M
Revenue (ttm)	2.4M
Net income (ttm)	-106.6M
EPS (ttm)	-$8.88
Shares out	14.7M
Volume	240,967
Beta	2.36

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.4M
Net income (ttm): -106.6M
EPS (ttm): -$8.88
Market cap: 203.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantener

Metric	Value
Amount currency	USD
CIK code	0001703647
Company name	Korro Bio, Inc.
Country	United States
Country code	US
CUSIP number	500946108
Earnings date	2026-11-11
Earnings time	amc
Employees	57
Employees change	-35
Employees growth	-38.04%
Enterprise value	$107.8M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2014
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2019-10-03
Is primary listing	Yes
Is SPAC	No
ISIN number	US5009461089
Last 10-K release date	2026-03-12
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$203.5M
Market cap category	Micro-Cap
Next earnings date	2026-11-11
Options	Yes
Price	$13.82
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	KRRO
U.S. state	Massachusetts
Website	https://www.korrobio.com

Metric

Value

Amount currency

USD

CIK code

0001703647

Company name

Korro Bio, Inc.

Country

United States

Country code

CUSIP number

500946108

Earnings date

2026-11-11

Earnings time

amc

Employees

Employees change

-35

Employees growth

-38.04%

Enterprise value

$107.8M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2014

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2019-10-03

Is primary listing

Yes

Is SPAC

ISIN number

US5009461089

Last 10-K release date

2026-03-12

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$203.5M

Market cap category

Micro-Cap

Next earnings date

2026-11-11

Options

Yes

Price

$13.82

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

KRRO

U.S. state

Massachusetts

Website

https://www.korrobio.com

Metric	Value
Earnings yield	-64.23%
EV/Sales	44.24x
FCF / EV yield	-64.79%
FCF yield	-33.95%
Forward EV/Sales	120.42x
Forward P/S	229.8x
P/B ratio	1.89x
P/S ratio	84.42x
Price / tangible book value	1.95x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-64.23%

EV/Sales

44.24x

FCF / EV yield

-64.79%

FCF yield

-33.95%

Forward EV/Sales

120.42x

Forward P/S

229.8x

P/B ratio

1.89x

P/S ratio

84.42x

Price / tangible book value

1.95x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Operating margin	-3,228.34%
Pretax margin	-4,441.86%
Profit per employee	$-1.9M
Revenue per employee	$41,789
ROA	-27.95%
ROCE	-50.99%
ROE	-97.69%
ROIC	-31.5%
SBC / revenue	391.69%
Tax / revenue	35.22%

Metric

Value

Operating margin

-3,228.34%

Pretax margin

-4,441.86%

Profit per employee

$-1.9M

Revenue per employee

$41,789

ROA

-27.95%

ROCE

-50.99%

ROE

-97.69%

ROIC

-31.5%

SBC / revenue

391.69%

Tax / revenue

35.22%

Metric	Value
EPS growth quarters	2
EPS growth years	0
Net income growth quarters	2
Net income growth years	0
Revenue growth	-62.08%
Revenue growth years	1

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth

-62.08%

Revenue growth years

Metric	Value
Capital expenditures	$-317,000
Depreciation and amortization	$2.6M
EBIT	$-76.9M
EBITDA	$-74.3M
EPS	$-8.88
FCF per share	$-4.64
Financing cash flow	$85.8M
Free cash flow	$-68.3M
Free cash flow minus SBC	$-77.6M
Gross profit	$-41M
Income taxes	$839,000
Investing cash flow	$-27.6M
Net cash flow	$-9.7M
Net income	$-106.6M
Operating cash flow minus SBC	$-77.3M
Operating income	$-76.9M
Revenue	$2.4M
Stock-based compensation	$9.3M

Metric

Value

Capital expenditures

$-317,000

Depreciation and amortization

$2.6M

EBIT

$-76.9M

EBITDA

$-74.3M

EPS

$-8.88

FCF per share

$-4.64

Financing cash flow

$85.8M

Free cash flow

$-68.3M

Free cash flow minus SBC

$-77.6M

Gross profit

$-41M

Income taxes

$839,000

Investing cash flow

$-27.6M

Net cash flow

$-9.7M

Net income

$-106.6M

Operating cash flow minus SBC

$-77.3M

Operating income

$-76.9M

Revenue

$2.4M

Stock-based compensation

$9.3M

Metric	Value
Altman Z-Score	-2.55
Book value per share	$7.02
Debt / equity	0.41
Interest coverage	-89.63
Long-term assets	$42.8M
Long-term liabilities	$47.6M
Net cash (debt)	$95.7M
Net cash / market cap	47.6%
Net cash growth	27.62%
Net debt / equity	-0.93
Piotroski F-Score	2
Property, plant and equipment	$15.1M
Shareholders' equity	$103.2M
Tangible book value	$103.2M
Tangible book value per share	$7.02
Total assets	$163.4M
Total cash	$115M
Total debt	$42.2M
Total liabilities	$60.2M
WACC	14.52%

Metric

Value

Altman Z-Score

-2.55

Book value per share

$7.02

Debt / equity

0.41

Interest coverage

-89.63

Long-term assets

$42.8M

Long-term liabilities

$47.6M

Net cash (debt)

$95.7M

Net cash / market cap

47.6%

Net cash growth

27.62%

Net debt / equity

-0.93

Piotroski F-Score

Property, plant and equipment

$15.1M

Shareholders' equity

$103.2M

Tangible book value

$103.2M

Tangible book value per share

$7.02

Total assets

$163.4M

Total cash

$115M

Total debt

$42.2M

Total liabilities

$60.2M

WACC

14.52%

Metric	Value
Asset turnover	0.01
Current assets	$120.6M
Current liabilities	$12.6M
Current ratio	9.55
Net working capital	$-4.1M
Quick ratio	9.11
Working capital	$108M
Working capital turnover	0.02

Metric

Value

Asset turnover

0.01

Current assets

$120.6M

Current liabilities

$12.6M

Current ratio

9.55

Net working capital

$-4.1M

Quick ratio

9.11

Working capital

$108M

Working capital turnover

0.02

Metric	Value
Buyback yield / dilution	-28.33%
Dividend yield	0%
Shareholder yield	-28.33%

Metric

Value

Buyback yield / dilution

-28.33%

Dividend yield

Shareholder yield

-28.33%

Metric	Value
150-day SMA	$12.05
1D price change	3.91%
1M price change	42.63%
1M total return	42.63%
1W price change	44.6%
1W total return	44.6%
1Y price change	-65.51%
1Y return CAGR	-65.54%
1Y total return	-65.51%
20-day SMA	$10.29
200-day SMA	$11.88
3M price change	27.33%
3M total return	27.33%
50-day SMA	$11.37
50-day SMA vs 200-day SMA	50under200
52-week high	$42.70
52-week high date	2025-10-31
52-week low	$5.20
52-week low date	2025-12-02
6M price change	6.31%
6M total return	6.31%
All-time high	$98.00
All-time high date	2024-10-16
All-time low	$5.20
All-time low date	2025-12-02
Average true range (ATR)	$1.05
Average volume	203.1K
Beta (1Y)	3.16
Beta (2Y)	2.78
Beta (5Y)	2.36
Change from 52-week high	-67.63%
Change from 52-week low	165.57%
Change from all-time high	-86.07%
Change from all-time low	162.3%
Change from open	3.91%
Day's gap	0%
Dollar volume	$3.3M
High price	$14.06
Low price	$13.21
Monthly RSI	45.53
Open price	$13.30
Position in 52-week range	71.76%
Premarket change	0%
Premarket close	$13.30
Premarket price	$13.30
Previous close	$13.30
Price vs 150-day SMA	13.31%
Price vs 20-day SMA	32.65%
Price vs 200-day SMA	14.93%
Price vs 50-day SMA	20.1%
Relative volume	1.19
Return from IPO price	-2.46%
RSI	69.57
Sharpe ratio	0.05
Sortino ratio	0.1
Volume	241K
Weekly RSI	53.97
YTD price change	70.41%
YTD total return	70.41%

Metric

Value

150-day SMA

$12.05

1D price change

3.91%

1M price change

42.63%

1M total return

42.63%

1W price change

44.6%

1W total return

44.6%

1Y price change

-65.51%

1Y return CAGR

-65.54%

1Y total return

-65.51%

20-day SMA

$10.29

200-day SMA

$11.88

3M price change

27.33%

3M total return

27.33%

50-day SMA

$11.37

50-day SMA vs 200-day SMA

50under200

52-week high

$42.70

52-week high date

2025-10-31

52-week low

$5.20

52-week low date

2025-12-02

6M price change

6.31%

6M total return

6.31%

All-time high

$98.00

All-time high date

2024-10-16

All-time low

$5.20

All-time low date

2025-12-02

Average true range (ATR)

$1.05

Average volume

203.1K

Beta (1Y)

3.16

Beta (2Y)

2.78

Beta (5Y)

2.36

Change from 52-week high

-67.63%

Change from 52-week low

165.57%

Change from all-time high

-86.07%

Change from all-time low

162.3%

Change from open

3.91%

Day's gap

Dollar volume

$3.3M

High price

$14.06

Low price

$13.21

Monthly RSI

45.53

Open price

$13.30

Position in 52-week range

71.76%

Premarket change

Premarket close

$13.30

Premarket price

$13.30

Previous close

$13.30

Price vs 150-day SMA

13.31%

Price vs 20-day SMA

32.65%

Price vs 200-day SMA

14.93%

Price vs 50-day SMA

20.1%

Relative volume

1.19

Return from IPO price

-2.46%

RSI

69.57

Sharpe ratio

0.05

Sortino ratio

0.1

Volume

241K

Weekly RSI

53.97

YTD price change

70.41%

YTD total return

70.41%

Metric	Value
Float	10.6M
Float percentage	71.82%
Shares change (QoQ)	51.9%
Shares change (YoY)	28.33%
Shares held by insiders	0.8%
Shares held by institutions	70.11%
Shares outstanding	14.7M
Short % of float	15.84%
Short % of shares	11.38%
Short ratio	8.7 days

Metric

Value

Float

10.6M

Float percentage

71.82%

Shares change (QoQ)

51.9%

Shares change (YoY)

28.33%

Shares held by insiders

0.8%

Shares held by institutions

70.11%

Shares outstanding

14.7M

Short % of float

15.84%

Short % of shares

11.38%

Short ratio

8.7 days

Korro Bio, Inc. (KRRO)

Price

Financial snapshot

Fair-value bridge

Latest news · KRRO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All KRRO indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on KRRO

Frequently asked questions